Test-prop by Genesis is a premium-grade short-ester injectable androgen designed for rapid physiological uptake and precise hormonal control. Each 10ml multi-dose vial contains 100 mg/ml of pharmaceutical-grade Testosterone Propionate suspended in refined carrier oil. Unlike long-ester counterparts such as enanthate or cypionate, the propionate ester yields a significantly shorter active half-life, initiating noticeable increases in circulating plasma testosterone within 24 to 36 hours post-administration.
As the primary endogenous male androgen, testosterone binds directly to intracellular androgen receptors, stimulating protein synthesis, improving nitrogen retention, and accelerating neuromuscular recovery. The fast-acting pharmacokinetics of Testosterone Propionate make it exceptionally versatile for physique athletes aiming to maximize lean mass retention while minimizing water retention, making it particularly popular during cutting and pre-contest conditioning phases.
Due to the propionate ester's rapid clearance profile, regular injection frequencies are necessary to maintain stable serum androgen concentrations and avoid hormonal fluctuations. Subcutaneous or deep intramuscular injections are standard, typically targeted into the gluteal muscles, ventrogluteal region, or deltoids.
Because testosterone aromatizes into estradiol via the cytochrome P450 aromatase enzyme, monitoring estrogenic activity is critical. Elevated estrogen levels can induce gynecomastia, fluid accumulation, and hypertension. Sensitive individuals should consider co-administering an Aromatase Inhibitor (AI) such as Anastrozole or Exemestane based on regular blood work.
Exogenous administration causes feedback-mediated suppression of the hypothalamic-pituitary-testicular axis (HPTA). A thorough Post-Cycle Therapy (PCT) regimen should commence roughly 3 to 4 days after the final injection of Test-prop. Effective protocols typically employ selective estrogen receptor modulators (SERMs), including Clomiphene Citrate (Clomid) and Tamoxifen Citrate (Nolvadex), over a 4 to 6-week period to stimulate endogenous luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion.
Owing to its active biological half-life of roughly 24 to 36 hours, Test-prop must be administered either daily (ED) or every other day (EOD) to prevent peaks and troughs in serum hormone levels.
The shorter ester causes less perceptible extracellular water retention compared to extended esters like enanthate. This allows athletes to maintain a harder, more defined, and vascular appearance during caloric deficits.
Because the propionate ester clears the system rapidly, PCT should typically be initiated within 3 to 5 days following the final injection, ensuring seamless recovery of endogenous hormone production.
